Head to head for first-timers
Sesame vs Zealthy
Sesame and Zealthy both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
Sesame
Higher scoreRank #7 for first-timers · Grade B
Mama-Match
Best for: Moms who'd rather have FDA-approved brand-name medication and a real clinical visit than the lowest compounded price, and who don't mind separate subscription and medication bills.
Visit SesameZealthy
Rank #293 for first-timers · Grade C
Mama-Match
Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.
Visit ZealthyThe verdict for a first step
Sesame edges out Zealthy on the Mama-Match Score, 83 to 39 (B vs C). Moms who'd rather have FDA-approved brand-name medication and a real clinical visit than the lowest compounded price, and who don't mind separate subscription and medication bills.
Zealthy is still a genuine option — ⛔ FDA warning letter #716501 (Sept. 2025) and, in April 2026, the FTC and DOJ moved to seize the company and freeze its assets. Read that first. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | Sesame | Zealthy |
|---|---|---|
| Mama-Match Score | 83/100 · B | 39/100 · C |
| Overall rank | #7 | #293 |
| Semaglutide | Brand only (Wegovy pill from ~$149/mo) | $135/mo |
| Tirzepatide | Brand only (Zepbound ~$349–$499/mo) | $225/mo |
| Coverage | All 50 states | Most states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Mama-Match
Sesame
Rank #7 · Grade B
What we like
- A real video visit with a licensed clinician, plus labs and messaging in the subscription
- FDA-approved brand-name options (Wegovy pill, Ozempic, Zepbound) with the manufacturer's own label
- Transparent cash-pay marketplace pricing — no insurance needed, HSA/FSA commonly accepted
The caveats
- No longer offers low-cost compounded GLP-1s — it exited that market in 2025
- The subscription and the medication are billed separately, so the true monthly cost is higher than the headline
- Brand-name medication runs $149–$499/mo, well above the flat compounded programs
Mama-Match
Zealthy
Rank #293 · Grade C
What we like
- Low, published monthly pricing for semaglutide and tirzepatide
- Coverage in most states with a fast, low-friction signup
- Straightforward compounded model — you see the cost before you commit
The caveats
- ⛔ FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, for unlawful sale of unapproved and misbranded drugs over the internet — the letter names its own site
- April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
- The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Sesame and Zealthy with the other providers we review for women.
- Sesame vs CoreAge Rx
- Sesame vs Synergy Rx
- Sesame vs Form Health
- Zealthy vs CoreAge Rx
- Zealthy vs Eden
- Zealthy vs Hers
Or browse the full comparison hub.